Among patients with advanced ovarian carcinoma, who benefits from bevacizumab the most?
@article{ATM112158,
author = {Abdulaziz Babaier and Prafull Ghatage},
title = {Among patients with advanced ovarian carcinoma, who benefits from bevacizumab the most?},
journal = {Annals of Translational Medicine},
volume = {11},
number = {10},
year = {2023},
keywords = {},
abstract = {},
issn = {2305-5847}, url = {https://atm.amegroups.org/article/view/112158}
}